BR9611377A - Inibidor de trombina de ligação não lenta processo para preparar o mesmo composição farmacêutica e uso do inibidor de trombina - Google Patents
Inibidor de trombina de ligação não lenta processo para preparar o mesmo composição farmacêutica e uso do inibidor de trombinaInfo
- Publication number
- BR9611377A BR9611377A BR9611377A BR9611377A BR9611377A BR 9611377 A BR9611377 A BR 9611377A BR 9611377 A BR9611377 A BR 9611377A BR 9611377 A BR9611377 A BR 9611377A BR 9611377 A BR9611377 A BR 9611377A
- Authority
- BR
- Brazil
- Prior art keywords
- thrombin inhibitor
- prepare
- pharmaceutical composition
- binding process
- same pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95202982 | 1995-11-03 | ||
| EP95203554 | 1995-12-19 | ||
| PCT/EP1996/004785 WO1997017363A1 (en) | 1995-11-03 | 1996-10-30 | Thrombin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9611377A true BR9611377A (pt) | 1999-02-23 |
Family
ID=26139759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9611377A BR9611377A (pt) | 1995-11-03 | 1996-10-30 | Inibidor de trombina de ligação não lenta processo para preparar o mesmo composição farmacêutica e uso do inibidor de trombina |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6432921B2 (pt) |
| EP (1) | EP0858464B1 (pt) |
| JP (1) | JPH11515033A (pt) |
| KR (1) | KR19990067219A (pt) |
| CN (1) | CN1202902A (pt) |
| AR (1) | AR004254A1 (pt) |
| AT (1) | ATE239755T1 (pt) |
| AU (1) | AU712940B2 (pt) |
| BR (1) | BR9611377A (pt) |
| CA (1) | CA2235586A1 (pt) |
| CZ (1) | CZ133998A3 (pt) |
| DE (1) | DE69628027T2 (pt) |
| DK (1) | DK0858464T3 (pt) |
| ES (1) | ES2199302T3 (pt) |
| HU (1) | HUP9900728A3 (pt) |
| IL (1) | IL119466A (pt) |
| NO (1) | NO981965L (pt) |
| PL (1) | PL326863A1 (pt) |
| PT (1) | PT858464E (pt) |
| RU (1) | RU2178796C2 (pt) |
| TR (1) | TR199800773T2 (pt) |
| TW (1) | TW486459B (pt) |
| WO (1) | WO1997017363A1 (pt) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL121474A0 (en) * | 1996-08-23 | 1998-02-08 | Akzo Nobel Nv | Thrombin inhibitors |
| WO1998016523A2 (en) * | 1996-10-11 | 1998-04-23 | Cor Therapeutics, Inc. | Selective factor xa inhibitors |
| US6063794A (en) | 1996-10-11 | 2000-05-16 | Cor Therapeutics Inc. | Selective factor Xa inhibitors |
| US6262047B1 (en) | 1996-10-11 | 2001-07-17 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6369080B2 (en) | 1996-10-11 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6194435B1 (en) | 1996-10-11 | 2001-02-27 | Cor Therapeutics, Inc. | Lactams as selective factor Xa inhibitors |
| CA2285705A1 (en) * | 1997-04-14 | 1998-10-22 | Cor Therapeutics, Inc. | Selective factor xa inhibitors |
| US6369063B1 (en) | 1997-04-14 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| WO1998046626A1 (en) | 1997-04-14 | 1998-10-22 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
| AU747531B2 (en) | 1997-04-14 | 2002-05-16 | Millennium Pharmaceuticals, Inc. | Selective factor Xa inhibitors |
| EP0884325A1 (en) * | 1997-04-24 | 1998-12-16 | Akzo Nobel N.V. | Thrombin inhibitors containing a peptidyl heterocycle |
| US5877156A (en) * | 1997-04-24 | 1999-03-02 | Akzo Nobel, N.V. | Thrombin inhibitors |
| CA2287569A1 (en) * | 1997-05-02 | 1998-11-12 | Akzo Nobel Nv | Serine protease inhibitors |
| AU7292398A (en) | 1997-05-15 | 1998-12-08 | Eli Lilly And Company | Antithrombotic compound |
| US6218382B1 (en) | 1997-08-11 | 2001-04-17 | Cor Therapeutics, Inc | Selective factor Xa inhibitors |
| US6333321B1 (en) | 1997-08-11 | 2001-12-25 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6228854B1 (en) | 1997-08-11 | 2001-05-08 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| CN1353701A (zh) * | 1999-01-27 | 2002-06-12 | 奥索-麦克尼尔药品公司 | 用作类胰蛋白酶抑制剂的肽基杂环酮类化合物 |
| US6344450B1 (en) * | 1999-02-09 | 2002-02-05 | Bristol-Myers Squibb Company | Lactam compounds and their use as inhibitors of serine proteases and method |
| US7405210B2 (en) * | 2003-05-21 | 2008-07-29 | Osi Pharmaceuticals, Inc. | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
| WO2005085245A1 (en) | 2004-03-08 | 2005-09-15 | Prosidion Limited | Pyrrolopyridine-2-carboxylic acid hydrazides |
| PT1737889E (pt) | 2004-10-19 | 2010-12-13 | Lonza Ag | Método para síntese de péptidos em fase sólida |
| ATE424821T1 (de) | 2004-12-02 | 2009-03-15 | Prosidion Ltd | Pyrrolopyridin-2-karbonsäureamide |
| AU2007253819B2 (en) | 2006-05-23 | 2011-02-17 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| EP2117537A1 (en) | 2007-02-09 | 2009-11-18 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| SG187271A1 (en) * | 2011-07-07 | 2013-02-28 | Agency Science Tech & Res | Anti-amyloidogenic, alpha-helix breaking ultra-small peptide therapeutic |
| AU2015328385B2 (en) | 2014-10-06 | 2020-06-11 | Lighthouse Pharmaceuticals, Inc. | Inhibitors of lysine gingipain |
| JP6877424B2 (ja) | 2015-11-09 | 2021-05-26 | コーテクシーミー， インコーポレイテッド | アルギニンジンジパインの阻害剤 |
| KR20190072530A (ko) | 2016-09-16 | 2019-06-25 | 코텍자임, 인코포레이티드 | 리신 진지파인의 케톤 억제제 |
| IL294127B2 (en) * | 2017-05-25 | 2024-07-01 | Jw Pharmaceutical Corp | A method for preparing a compound of a heterocyclic derivative, a preparation containing this compound and a hydrate of the compound |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EE9700113A (et) * | 1994-12-22 | 1997-12-15 | Biochem Pharma Inc. | Madala molekulmassiga bitsüklilised trombiini inhibiitorid |
| US5827866A (en) * | 1995-06-07 | 1998-10-27 | Ortho Pharmaceutical Corporation | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| US5827860A (en) * | 1995-06-07 | 1998-10-27 | Ortho Pharmaceutical Corporation | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| US5523308A (en) * | 1995-06-07 | 1996-06-04 | Costanzo; Michael J. | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
-
1996
- 1996-10-22 IL IL11946696A patent/IL119466A/xx not_active IP Right Cessation
- 1996-10-30 DK DK96937337T patent/DK0858464T3/da active
- 1996-10-30 CZ CZ981339A patent/CZ133998A3/cs unknown
- 1996-10-30 US US09/068,074 patent/US6432921B2/en not_active Expired - Fee Related
- 1996-10-30 EP EP96937337A patent/EP0858464B1/en not_active Expired - Lifetime
- 1996-10-30 DE DE69628027T patent/DE69628027T2/de not_active Expired - Fee Related
- 1996-10-30 WO PCT/EP1996/004785 patent/WO1997017363A1/en not_active Application Discontinuation
- 1996-10-30 HU HU9900728A patent/HUP9900728A3/hu unknown
- 1996-10-30 AU AU74975/96A patent/AU712940B2/en not_active Ceased
- 1996-10-30 PL PL96326863A patent/PL326863A1/xx unknown
- 1996-10-30 RU RU98110641/04A patent/RU2178796C2/ru not_active IP Right Cessation
- 1996-10-30 BR BR9611377A patent/BR9611377A/pt unknown
- 1996-10-30 ES ES96937337T patent/ES2199302T3/es not_active Expired - Lifetime
- 1996-10-30 JP JP9517828A patent/JPH11515033A/ja not_active Ceased
- 1996-10-30 TR TR1998/00773T patent/TR199800773T2/xx unknown
- 1996-10-30 KR KR1019980703176A patent/KR19990067219A/ko not_active Application Discontinuation
- 1996-10-30 PT PT96937337T patent/PT858464E/pt unknown
- 1996-10-30 AT AT96937337T patent/ATE239755T1/de not_active IP Right Cessation
- 1996-10-30 CN CN96198628A patent/CN1202902A/zh active Pending
- 1996-10-30 CA CA002235586A patent/CA2235586A1/en not_active Abandoned
- 1996-11-01 AR ARP960104997A patent/AR004254A1/es unknown
- 1996-11-04 TW TW085113438A patent/TW486459B/zh active
-
1998
- 1998-04-30 NO NO981965A patent/NO981965L/no not_active Application Discontinuation
-
2002
- 2002-01-04 US US10/039,737 patent/US20020142967A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2199302T3 (es) | 2004-02-16 |
| HUP9900728A3 (en) | 2000-12-28 |
| US20020142967A1 (en) | 2002-10-03 |
| WO1997017363A1 (en) | 1997-05-15 |
| MX9803479A (es) | 1998-09-30 |
| TW486459B (en) | 2002-05-11 |
| AU7497596A (en) | 1997-05-29 |
| DK0858464T3 (da) | 2003-08-25 |
| CA2235586A1 (en) | 1997-05-15 |
| RU2178796C2 (ru) | 2002-01-27 |
| TR199800773T2 (xx) | 1998-08-21 |
| EP0858464A1 (en) | 1998-08-19 |
| CZ133998A3 (cs) | 1998-09-16 |
| PT858464E (pt) | 2003-08-29 |
| JPH11515033A (ja) | 1999-12-21 |
| IL119466A (en) | 2001-08-26 |
| EP0858464B1 (en) | 2003-05-07 |
| IL119466A0 (en) | 1997-01-10 |
| US20010007764A1 (en) | 2001-07-12 |
| US6432921B2 (en) | 2002-08-13 |
| AR004254A1 (es) | 1998-11-04 |
| AU712940B2 (en) | 1999-11-18 |
| KR19990067219A (ko) | 1999-08-16 |
| ATE239755T1 (de) | 2003-05-15 |
| CN1202902A (zh) | 1998-12-23 |
| DE69628027D1 (en) | 2003-06-12 |
| NO981965D0 (no) | 1998-04-30 |
| NO981965L (no) | 1998-06-30 |
| DE69628027T2 (de) | 2004-04-08 |
| HUP9900728A2 (hu) | 1999-08-30 |
| PL326863A1 (en) | 1998-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9611377A (pt) | Inibidor de trombina de ligação não lenta processo para preparar o mesmo composição farmacêutica e uso do inibidor de trombina | |
| BR9611986A (pt) | Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos | |
| BR9406566A (pt) | Composição farmacêutica uso de progesterona e/ou 17 - - estradiol e processo para a fabricação de uma preparação farmacêutica | |
| BR9600146A (pt) | Mistura composição processo para estabilizar material orgânico e uso | |
| BR9509710A (pt) | Composições para hemorróidas e método de uso | |
| BR9602705A (pt) | Composto composição farmacéutica processo para a preparação de um composto e uso | |
| BR9504359A (pt) | Composto composição processo para estabilizar material orgânico e uso | |
| BR9612135A (pt) | Taxóides processo para sua preparação e composiç o farmacêutica | |
| BR9508586A (pt) | Compostos processo de preparação dos mesmos uso dos mesmos processo de tratamento de uma condição clínica em um mamífero e composição farmacêutica | |
| BR9506561A (pt) | Co-grânulo homogêneo composição detergente tablete de detergente processos para sua preparação e uso dos mesmos | |
| BR9504072A (pt) | Composiçao farmacêutica métodos para o tratamento de hipercolesterolemia de aterosclerose e kit | |
| BR9612148A (pt) | Composição formulação farmacêutica uso e processo para preparação de um composto e para tratamento de uma condição onde a trombina seja necessária | |
| BR9504998A (pt) | Composições cosméticas de uso tópico utilização de composições processo de tratamento cosmético e utilização de uma mistura | |
| BR9706311A (pt) | Compostos de estilbeno composição farmacêutica composição cosmética e uso de uma composição cosmética | |
| BR9610180A (pt) | Composição líquida autodepositante e processo para sua preparação | |
| EE04500B1 (et) | Trombiini inhibiitorid, nende saamine ja kasutamine | |
| BR9600930A (pt) | Derivados de n-(3-benzofuranil)uréia processo para sua preparação composição processo para a preparação de composições e uso | |
| BR9608685A (pt) | Composição solida expandida processo de preparação de uma composição e composição para uso cosmético ou dermatológico | |
| BR9609330A (pt) | Derivado de difenilmetileno piperidina composição farmacêutica e processo para preparação e uso do derivado de difenilmetileno piperidina | |
| BR9510509A (pt) | Composto composição farmacêutica ou cosmética uso de uma composição e processo para prevenir e/ou combater o envelhecimento da pele | |
| BR9711968A (pt) | Composi-Æo aquosa uso de uma composi-Æo e processo para preparar a mesma | |
| BR9206950A (pt) | Composição farmacêutica e processo para sua preparação | |
| BR8902306A (pt) | Composicao e processo para sua preparacao | |
| BR9609695A (pt) | Composição herbicida sinérgica e processo para seu uso | |
| BR9500884A (pt) | Composições cosméticas de uso tópico processo de preparação de composições utilização de composições e processo de tratamento cosmético |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A ANUIDADES. |